Literature DB >> 25687276

Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.

Madeleine Witting1, Katja Obst2, Wolfgang Friess1, Sarah Hedtrich3.   

Abstract

Proteins and peptides are increasingly important therapeutics for the treatment of severe and complex diseases like cancer or autoimmune diseases due to their high specificity and potency. Their unique structure and labile physicochemical properties, however, require special attention in the production and formulation process as well as during administration. Aside from conventional systemic injections, the topical application of proteins and peptides is an appealing alternative due to its non-invasive nature and thus high acceptance by patients. For this approach, soft matter nanocarriers are interesting delivery systems which offer beneficial properties such as high biocompatibility, easiness of modifications, as well as targeted drug delivery and release. This review aims to highlight and discuss technological developments in the field of soft matter nanocarriers for the delivery of proteins and peptides via the skin, the eye, the nose, and the lung, and to provide insights in advantages, limitations, and practicability of recent advances.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopharmaceuticals; Dermal; Nasal; Ocular; Peptides; Proteins; Pulmonary; Soft matter nanocarrier; Targeted drug delivery; Topical delivery

Mesh:

Substances:

Year:  2015        PMID: 25687276     DOI: 10.1016/j.biotechadv.2015.01.010

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  13 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 2.  Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Authors:  Vibhuti Agrahari; Vivek Agrahari; Ashim K Mitra
Journal:  Ther Deliv       Date:  2016

Review 3.  The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures.

Authors:  Atefeh Parchebafi; Farzaneh Tamanaee; Hassan Ehteram; Ejaz Ahmad; Hossein Nikzad; Hamed Haddad Kashani
Journal:  Microb Cell Fact       Date:  2022-06-18       Impact factor: 6.352

4.  In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.

Authors:  Fang Xie; Rui-Lin Ding; Wen-Feng He; Zong-Jun-Lin Liu; Shao-Zhi Fu; Jing-Bo Wu; Ling-Lin Yang; Sheng Lin; Qing-Lian Wen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 5.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

Authors:  Margit Mahlapuu; Joakim Håkansson; Lovisa Ringstad; Camilla Björn
Journal:  Front Cell Infect Microbiol       Date:  2016-12-27       Impact factor: 5.293

Review 6.  Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2016-10-27

7.  TopicalPdb: A database of topically delivered peptides.

Authors:  Deepika Mathur; Ayesha Mehta; Priyanka Firmal; Gursimran Bedi; Charu Sood; Ankur Gautam; Gajendra P S Raghava
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

Review 8.  Strategies to Develop a Suitable Formulation for Inflammatory Skin Disease Treatment.

Authors:  Jiun-Wen Guo; Shiou-Hwa Jee
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

9.  Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

Authors:  Meng Zhang; Ergang Liu; Yanna Cui; Yongzhuo Huang
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

Review 10.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.